W. Strube et al., A GE DELETED INFECTIOUS BOVINE-RHINOTRACHEITIS MARKER VACCINE FOR USEIN IMPROVED BOVINE HERPESVIRUS-1 CONTROL PROGRAMS, Veterinary microbiology, 53(1-2), 1996, pp. 181-189
Based on a glycoprotein E (gE) deleted bovine herpesvirus 1 (BHV1) str
ain (Kaashoek et al., 1994) a killed virus as well as a modified live
virus marker vaccine have been developed that allow differentiation be
tween immunized and BHV1 infected cattle. Safety and efficacy of both
vaccines were tested extensively following the current European Union
(EU) requirements for the development of bovine vaccines. The minimum
vaccine dose, vaccination regimen, route of administration and duratio
n of immunity were evaluated for both vaccines in comprehensive vaccin
ation/challenge trials in cattle. The most potent adjuvant formulation
for the killed virus vaccine was also selected by experimental challe
nge infections. For the modified live virus marker vaccine it could be
demonstrated that maternally derived BHV1 specific antibodies did not
interfere with vaccination. Safety could be demonstrated for both the
killed virus and the modified live virus vaccine in all target animal
categories including veal calves, beef cattle, bulls, heifers and dai
ry cattle, including pregnant animals.